382 related articles for article (PubMed ID: 15539606)
1. Multidimensional drug profiling by automated microscopy.
Perlman ZE; Slack MD; Feng Y; Mitchison TJ; Wu LF; Altschuler SJ
Science; 2004 Nov; 306(5699):1194-8. PubMed ID: 15539606
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule screening and profiling by using automated microscopy.
Mitchison TJ
Chembiochem; 2005 Jan; 6(1):33-9. PubMed ID: 15568196
[TBL] [Abstract][Full Text] [Related]
3. The potential of high-content high-throughput microscopy in drug discovery.
Starkuviene V; Pepperkok R
Br J Pharmacol; 2007 Sep; 152(1):62-71. PubMed ID: 17603554
[TBL] [Abstract][Full Text] [Related]
4. Image-based multivariate profiling of drug responses from single cells.
Loo LH; Wu LF; Altschuler SJ
Nat Methods; 2007 May; 4(5):445-53. PubMed ID: 17401369
[TBL] [Abstract][Full Text] [Related]
5. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
6. Identification of gap junction blockers using automated fluorescence microscopy imaging.
Li Z; Yan Y; Powers EA; Ying X; Janjua K; Garyantes T; Baron B
J Biomol Screen; 2003 Oct; 8(5):489-99. PubMed ID: 14567776
[TBL] [Abstract][Full Text] [Related]
7. Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye.
Pernelle K; Le Guevel R; Glaise D; Stasio CG; Le Charpentier T; Bouaita B; Corlu A; Guguen-Guillouzo C
Toxicol Appl Pharmacol; 2011 Aug; 254(3):256-66. PubMed ID: 21569786
[TBL] [Abstract][Full Text] [Related]
8. A fluorescence-based rapid screening assay for cytotoxic compounds.
Montoya J; Varela-Ramirez A; Estrada A; Martinez LE; Garza K; Aguilera RJ
Biochem Biophys Res Commun; 2004 Dec; 325(4):1517-23. PubMed ID: 15555600
[TBL] [Abstract][Full Text] [Related]
9. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
[TBL] [Abstract][Full Text] [Related]
10. High-throughput RNAi screening by time-lapse imaging of live human cells.
Neumann B; Held M; Liebel U; Erfle H; Rogers P; Pepperkok R; Ellenberg J
Nat Methods; 2006 May; 3(5):385-90. PubMed ID: 16628209
[TBL] [Abstract][Full Text] [Related]
11. Automated image analysis for high-content screening and analysis.
Shariff A; Kangas J; Coelho LP; Quinn S; Murphy RF
J Biomol Screen; 2010 Aug; 15(7):726-34. PubMed ID: 20488979
[TBL] [Abstract][Full Text] [Related]
12. The application of human embryonic stem cell technologies to drug discovery.
Sartipy P; Björquist P; Strehl R; Hyllner J
Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
[TBL] [Abstract][Full Text] [Related]
13. Image analysis benchmarking methods for high-content screen design.
Fuller CJ; Straight AF
J Microsc; 2010 May; 238(2):145-61. PubMed ID: 20529062
[TBL] [Abstract][Full Text] [Related]
14. Automated classification of mitotic phenotypes of human cells using fluorescent proteins.
Harder N; Eils R; Rohr K
Methods Cell Biol; 2008; 85():539-54. PubMed ID: 18155478
[TBL] [Abstract][Full Text] [Related]
15. Live cell imaging: an industrial perspective.
McCann T
Methods Mol Biol; 2010; 591():47-66. PubMed ID: 19957123
[TBL] [Abstract][Full Text] [Related]
16. Integrating high-content screening and ligand-target prediction to identify mechanism of action.
Young DW; Bender A; Hoyt J; McWhinnie E; Chirn GW; Tao CY; Tallarico JA; Labow M; Jenkins JL; Mitchison TJ; Feng Y
Nat Chem Biol; 2008 Jan; 4(1):59-68. PubMed ID: 18066055
[TBL] [Abstract][Full Text] [Related]
17. Image-based chemical screening.
Carpenter AE
Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
[TBL] [Abstract][Full Text] [Related]
18. Development and submission of a nonclinical (pharmacology/toxicology) CANDA.
Coleman JB; Wise LD; Greenberg WP; Orfe D; Jarossy N; Eydelloth RS; Peter CP; Spence S; Lankas GR
Regul Toxicol Pharmacol; 1995 Aug; 22(1):46-53. PubMed ID: 7494902
[TBL] [Abstract][Full Text] [Related]
19. An infrastructure for high-throughput microscopy: instrumentation, informatics, and integration.
Vaisberg EA; Lenzi D; Hansen RL; Keon BH; Finer JT
Methods Enzymol; 2006; 414():484-512. PubMed ID: 17110208
[TBL] [Abstract][Full Text] [Related]
20. Development and implementation of multiplexed cell-based imaging assays.
Howell BJ; Lee S; Sepp-Lorenzino L
Methods Enzymol; 2006; 414():284-300. PubMed ID: 17110198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
